Home » Biovail Receives Canadian Approval for Ralivia
Biovail Receives Canadian Approval for Ralivia
Biovail Corporation announced that the Therapeutic Products Directorate (TPD) Canada has issued a Notice of Compliance (NOC) for 100mg, 200mg and 300mg tablet strengths of Ralivia, the Company’s once-daily, extended-release formulation of tramadol hydrochloride indicated for the management of pain of moderate severity in patients who require continuous treatment for several days or more.
Yahoo! Finance
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May